Journal article · 2026 · Open access
Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs
Veterinary Pathology, 63(3), 445–461 · Published 4 March 2026 · DOI 10.1177/03009858261423132
In brief
“Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs” is a 2026 journal article by Anna Maria Giusti and 4 co-authors, published in Veterinary Pathology. OpenAlex counts 3 citations as of 17 November 2026, which puts it in the top 4% of works published in 2026 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Veterinary Pathology.
- Citations
- 3
- Most cited in
- 2026 (3)
- Field-weighted impact
- 5.70
- References
- 57
- Authors
- 5
Abstract
Humanized mice engrafted with human CD34+ hematopoietic stem cells (HSCs) are invaluable models for the preclinical evaluation of cancer immunotherapy drugs, helping to bridge the gap between in vitro studies and clinical trials. However, there are inherent challenges associated with these models, which require careful consideration, as they can obscure the distinction between treatment-related effects and model-specific background lesions. Here, we provide a comprehensive overview of common histopathological changes in such models, focusing on humanized nonobese diabetic (NOD) Cg- Prkdc scid Il2rg tm1Wjl/SzJ (huNSG) mice engrafted with human CD34+ HSCs. We characterize engraftment kinetics and histopathological changes at various timepoints post-engraftment and provide examples of huNSG mice utilized to evaluate immuno-oncology compounds and how these drugs influenced the development of huNSG-related background lesions. Flow cytometry and immunohistochemistry analyses reveal dynamic changes in human immune cell populations, with a predominance of B cells over T cells at early timepoints, shifting to T cell predominance at later stages. Notably, spontaneous granulomatous lesions, dominated by human macrophages, are observed in multiple organs, which increase in incidence and severity over time. These lesions are exacerbated by immunostimulatory treatments, highlighting the need for careful interpretation of drug-induced effects vs model-specific background pathology. Additionally, bone marrow necrosis that resembles ischemic lesions is identified in some huNSG mice, particularly following immune stimulation. Our findings underscore the critical importance of understanding the inherent pathological changes in huNSG mice to accurately assess the safety of cancer immunotherapy drugs.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Giusti, A. M., Sam, J., Colombetti, S., Veiga, I. B., & Rodríguez, J. M. M. (2026). Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs. Veterinary Pathology, 63(3), 445–461. https://doi.org/10.1177/03009858261423132
MLA 9
Giusti, Anna Maria, et al. “Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs.” Veterinary Pathology, vol. 63, no. 3, 2026, pp. 445–461. https://doi.org/10.1177/03009858261423132.
Chicago
Giusti, Anna Maria, Johannes Sam, Sara Colombetti, Inês Berenguer Veiga, and Josep M. Monné Rodríguez. 2026. “Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs.” Veterinary Pathology 63 (3): 445–461. https://doi.org/10.1177/03009858261423132.
Harvard
Giusti, A. M. et al. (2026) ‘Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs’, Veterinary Pathology, 63(3), pp. 445–461. doi:10.1177/03009858261423132.
IEEE
A. M. Giusti, J. Sam, S. Colombetti, I. B. Veiga, and J. M. M. Rodríguez, “Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs,” Veterinary Pathology, vol. 63, no. 3, pp. 445–461, 2026, doi: 10.1177/03009858261423132.
BibTeX
@article{giusti2026pathological,
title = {{Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs}},
author = {Giusti, Anna Maria and Sam, Johannes and Colombetti, Sara and Veiga, Inês Berenguer and Rodríguez, Josep M. Monné},
journal = {Veterinary Pathology},
year = {2026},
volume = {63},
number = {3},
pages = {445--461},
doi = {10.1177/03009858261423132},
url = {https://doi.org/10.1177/03009858261423132}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- humanized mice
- cancer immunotherapy
- drug safety assessment
- histopathology
- granuloma
- human macrophages
- bone marrow necrosis
- immune cell composition
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Giusti, A. M., Sam, J., Colombetti, S., Veiga, I. B., & Rodríguez, J. M. M. (2026). Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs. Veterinary Pathology, 63(3), 445–461. https://doi.org/10.1177/03009858261423132
How many times has this paper been cited?
3 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Veterinary Pathology: sign in and open the full text from this page.
Who wrote this paper?
Anna Maria Giusti, Johannes Sam, Sara Colombetti, Inês Berenguer Veiga, Josep M. Monné Rodríguez.
What is the DOI of this paper?
10.1177/03009858261423132, permanently at https://doi.org/10.1177/03009858261423132. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.